BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 18408133)

  • 1. Impaired relaxation is the main manifestation in transgenic mice expressing a restrictive cardiomyopathy mutation, R193H, in cardiac TnI.
    Du J; Liu J; Feng HZ; Hossain MM; Gobara N; Zhang C; Li Y; Jean-Charles PY; Jin JP; Huang XP
    Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2604-13. PubMed ID: 18408133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-dependent diastolic dysfunction and early death in a mouse model with cardiac troponin mutations.
    Li Y; Zhang L; Jean-Charles PY; Nan C; Chen G; Tian J; Jin JP; Gelb IJ; Huang X
    J Mol Cell Cardiol; 2013 Sep; 62():227-36. PubMed ID: 23810866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correcting diastolic dysfunction by Ca2+ desensitizing troponin in a transgenic mouse model of restrictive cardiomyopathy.
    Li Y; Charles PY; Nan C; Pinto JR; Wang Y; Liang J; Wu G; Tian J; Feng HZ; Potter JD; Jin JP; Huang X
    J Mol Cell Cardiol; 2010 Sep; 49(3):402-11. PubMed ID: 20580639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diastolic dysfunction and thin filament dysregulation resulting from excitation-contraction uncoupling in a mouse model of restrictive cardiomyopathy.
    Davis J; Yasuda S; Palpant NJ; Martindale J; Stevenson T; Converso K; Metzger JM
    J Mol Cell Cardiol; 2012 Sep; 53(3):446-57. PubMed ID: 22683325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A point mutation (R192H) in the C-terminus of human cardiac troponin I causes diastolic dysfunction in transgenic mice.
    Du J; Zhang C; Liu J; Sidky C; Huang XP
    Arch Biochem Biophys; 2006 Dec; 456(2):143-50. PubMed ID: 17027633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thin filament disinhibition by restrictive cardiomyopathy mutant R193H troponin I induces Ca2+-independent mechanical tone and acute myocyte remodeling.
    Davis J; Wen H; Edwards T; Metzger JM
    Circ Res; 2007 May; 100(10):1494-502. PubMed ID: 17463320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive troponin I loss impairs cardiac relaxation and causes heart failure in mice.
    Liu J; Du J; Zhang C; Walker JW; Huang X
    Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H1273-81. PubMed ID: 17526646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic regulation of phosphodiesterase 4d in restrictive cardiomyopathy mice with cTnI mutations.
    Zhao W; Wu X; Wang Z; Pan B; Liu L; Liu L; Huang X; Tian J
    Sci China Life Sci; 2020 Apr; 63(4):563-570. PubMed ID: 30900165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dominantly negative mutation in cardiac troponin I at the interface with troponin T causes early remodeling in ventricular cardiomyocytes.
    Wei H; Jin JP
    Am J Physiol Cell Physiol; 2014 Aug; 307(4):C338-48. PubMed ID: 24898585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypercontractile mutant of ventricular myosin essential light chain leads to disruption of sarcomeric structure and function and results in restrictive cardiomyopathy in mice.
    Yuan CC; Kazmierczak K; Liang J; Kanashiro-Takeuchi R; Irving TC; Gomes AV; Wang Y; Burghardt TP; Szczesna-Cordary D
    Cardiovasc Res; 2017 Aug; 113(10):1124-1136. PubMed ID: 28371863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium desensitizer catechin reverses diastolic dysfunction in mice with restrictive cardiomyopathy.
    Zhang L; Nan C; Chen Y; Tian J; Jean-Charles PY; Getfield C; Wang X; Huang X
    Arch Biochem Biophys; 2015 May; 573():69-76. PubMed ID: 25813360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allele and species dependent contractile defects by restrictive and hypertrophic cardiomyopathy-linked troponin I mutants.
    Davis J; Wen H; Edwards T; Metzger JM
    J Mol Cell Cardiol; 2008 May; 44(5):891-904. PubMed ID: 18423659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long term ablation of protein kinase A (PKA)-mediated cardiac troponin I phosphorylation leads to excitation-contraction uncoupling and diastolic dysfunction in a knock-in mouse model of hypertrophic cardiomyopathy.
    Dweck D; Sanchez-Gonzalez MA; Chang AN; Dulce RA; Badger CD; Koutnik AP; Ruiz EL; Griffin B; Liang J; Kabbaj M; Fincham FD; Hare JM; Overton JM; Pinto JR
    J Biol Chem; 2014 Aug; 289(33):23097-23111. PubMed ID: 24973218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restrictive Cardiomyopathy Troponin I R145W Mutation Does Not Perturb Myofilament Length-dependent Activation in Human Cardiac Sarcomeres.
    Dvornikov AV; Smolin N; Zhang M; Martin JL; Robia SL; de Tombe PP
    J Biol Chem; 2016 Oct; 291(41):21817-21828. PubMed ID: 27557662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dilated cardiomyopathy mutation blunts adrenergic response and induces contractile dysfunction under chronic angiotensin II stress.
    Wilkinson R; Song W; Smoktunowicz N; Marston S
    Am J Physiol Heart Circ Physiol; 2015 Dec; 309(11):H1936-46. PubMed ID: 26432839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart Failure-Related Hyperphosphorylation in the Cardiac Troponin I C Terminus Has Divergent Effects on Cardiac Function In Vivo.
    Li Y; Zhu G; Paolocci N; Zhang P; Takahashi C; Okumus N; Heravi A; Keceli G; Ramirez-Correa G; Kass DA; Murphy AM
    Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28899987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The contributions of cardiac myosin binding protein C and troponin I phosphorylation to β-adrenergic enhancement of in vivo cardiac function.
    Gresham KS; Stelzer JE
    J Physiol; 2016 Feb; 594(3):669-86. PubMed ID: 26635197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sarcomere neutralization in inherited cardiomyopathy: small-molecule proof-of-concept to correct hyper-Ca2+-sensitive myofilaments.
    Thompson BR; Martindale J; Metzger JM
    Am J Physiol Heart Circ Physiol; 2016 Jul; 311(1):H36-43. PubMed ID: 27199134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired cardiomyocyte relaxation and diastolic function in transgenic mice expressing slow skeletal troponin I in the heart.
    Fentzke RC; Buck SH; Patel JR; Lin H; Wolska BM; Stojanovic MO; Martin AF; Solaro RJ; Moss RL; Leiden JM
    J Physiol; 1999 May; 517 ( Pt 1)(Pt 1):143-57. PubMed ID: 10226156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restrictive cardiomyopathy mutations demonstrate functions of the C-terminal end-segment of troponin I.
    Akhter S; Bueltmann K; Huang X; Jin JP
    Arch Biochem Biophys; 2014 Jun; 552-553():3-10. PubMed ID: 24326031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.